HI
VIR icon

Harbour Investments’s Vir Biotechnology VIR Stock Holding History

Harbour Investments’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-80
Closed -$805 – 3314
2023
Q4 		$805 Sell
80
-83
-51% -$758 ﹤0.01% 2860
2023
Q3 		$1.53K Hold
163
– – ﹤0.01% 2612
2023
Q2 		$4K Hold
163
– – ﹤0.01% 2354
2023
Q1 		$3.79K Hold
163
– – ﹤0.01% 2384
2022
Q4 		$4.13K Hold
163
– – ﹤0.01% 2278
2022
Q3 		$4K Hold
163
– – ﹤0.01% 2273
2022
Q2 		$4K Buy
+163
New +$3.81K ﹤0.01% 2273
2021
Q4 		$7K Sell
178
-1,704
-91% -$66.8K ﹤0.01% 2076
2021
Q3 		$82K Hold
1,882
– – ﹤0.01% 1494
2021
Q2 		$89K Hold
1,882
– – ﹤0.01% 1469
2021
Q1 		$96K Buy
+1,882
New +$101K ﹤0.01% 1319

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Harbour Investments's VIR Position: Q1 2024 in Review

Harbour Investments sold out of Vir Biotechnology (VIR) in Q1 2024, closing a stake of 80 shares — an estimated $805 sold.

Harbour Investments first reported a position in VIR in Q1 2021 and held it in 11 quarters. The position peaked at $96K in Q1 2021. 209 funds tracked by Wall St. Rank hold VIR as of Q1 2024.

  • Harbour Investments reported no remaining Vir Biotechnology position as of Q1 2024 after selling out during the quarter.
  • Harbour Investments sold 80 Vir Biotechnology shares in Q1 2024, an estimated $805.
  • Harbour Investments first reported a position in Vir Biotechnology in Q1 2021 and held it in 11 quarters.
  • Harbour Investments's Vir Biotechnology position peaked at $96K in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2024.

Based on Harbour Investments's 13F filing for Q1 2024, filed 22 Jul 2024.